These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34210732)

  • 21. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
    Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
    Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Options for screening for colorectal cancer.
    Atkin W
    Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
    Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anatomic distribution of cancers and colorectal adenomas according to age and sex and relationship between proximal and distal neoplasms in an i-FOBT-positive average-risk Italian screening cohort.
    Parente F; Bargiggia S; Boemo C; Vailati C; Bonoldi E; Ardizzoia A; Ilardo A; Tortorella F; Gallus S
    Int J Colorectal Dis; 2014 Jan; 29(1):57-64. PubMed ID: 23975054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study.
    Terhaar sive Droste JS; van Turenhout ST; Oort FA; van der Hulst RW; Steeman VA; Coblijn U; van der Eem L; Duijkers R; Bouman AA; Meijer GA; Depla AC; Scholten P; Loffeld RJ; Coupé VM; Mulder CJ
    BMC Gastroenterol; 2012 Jul; 12():94. PubMed ID: 22828158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term risk of colorectal cancer in individuals with serrated polyps.
    Holme Ø; Bretthauer M; Eide TJ; Løberg EM; Grzyb K; Løberg M; Kalager M; Adami HO; Kjellevold Ø; Hoff G
    Gut; 2015 Jun; 64(6):929-36. PubMed ID: 25399542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of the immunochemical fecal test (FIT) for detection of advanced adenomas in colorectal carcinoma screening in an asymptomatic population.
    Miuţescu B; Sporea I; Popescu A; Bota S; Iovănescu D; Burlea A; Mos L; Palaghia M; Vasilescu A; Miuţescu E
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):302-7. PubMed ID: 24340508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas.
    Lee JK; Roy A; Jensen CD; Chan JT; Zhao WK; Levin TR; Chubak J; Halm EA; Skinner CS; Schottinger JE; Ghai NR; Burnett-Hartman AN; Kamineni A; Udaltsova N; Corley DA
    JAMA Netw Open; 2024 Apr; 7(4):e244611. PubMed ID: 38564216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.
    Collins MG; Teo E; Cole SR; Chan CY; McDonald SP; Russ GR; Young GP; Bampton PA; Coates PT
    BMJ; 2012 Jul; 345():e4657. PubMed ID: 22833618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
    Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
    Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
    United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
    Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
    Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
    Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
    Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
    [No Abstract]   [Full Text] [Related]  

  • 35. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
    Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DIAGNOSTIC ACCURACY OF ONE SAMPLE OR TWO SAMPLES QUANTITATIVE FECAL IMMUNOCHEMICAL TESTS FOR INTESTINAL NEOPLASIA DETECTION.
    Mattar R; Marques SB; Minata MK; Silva-Etto JMKD; Sakai P; DE Moura EGH
    Arq Gastroenterol; 2020; 57(3):316-322. PubMed ID: 32935747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Piper MA; Perdue LA; Rutter CM; Webber EM; O'Connor E; Smith N; Whitlock EP
    JAMA; 2016 Jun; 315(23):2576-94. PubMed ID: 27305422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 5-year evaluation of early-and late-onset sporadic colorectal cancer screening in central Saudi Arabia.
    Zacharakis G; Almasoud A; Arahmaner O; Aldossary K; Alzahrani J; Al-Ghamdi S; AlShehri A; Nikolaidis P; Bawazir A; Alfayez T; Daadour M; Alslimah F; Altamimi M; Alshalawi S
    Saudi J Gastroenterol; 2023; 29(2):95-101. PubMed ID: 36254929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
    Graser A; Melzer A; Lindner E; Nagel D; Herrmann K; Stieber P; Schirra J; Mansmann U; Reiser MF; Göke B; Kolligs FT
    Gastroenterology; 2013 Apr; 144(4):743-750.e2. PubMed ID: 23415805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.